GW Henssler & Associates’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

GW Henssler & Associates’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-24,056	Closed	-$160K	–	213
2023 Q3	$160K	Buy	+24,056	New	+$200K	0.01%	201

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

GW Henssler & Associates's PNT Position: Q4 2023 in Review

GW Henssler & Associates sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 24,056 shares — an estimated $160K sold.

GW Henssler & Associates first reported a position in PNT in Q3 2023 and held it in 1 quarter. The position peaked at $160K in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

GW Henssler & Associates reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
GW Henssler & Associates sold 24,056 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $160K.
GW Henssler & Associates first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2023 and held it in 1 quarter.
GW Henssler & Associates's POINT Biopharma Global Inc. Common Stock position peaked at $160K in Q3 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on GW Henssler & Associates's 13F filing for Q4 2023, filed 26 Jan 2024.